EUVIMEDEUVIMED entdecken
Crossref

Abrus cantoniensis α-glucan-like polysaccharide alleviates influenza via gut microbial acetate to activate free fatty acid receptor 2/ mitochondrial antiviral signaling protein/interferon-beta pathway

Yuting Yi, Dongdong Li, Yuan Li, Haotong Wang, Daxin Yang, Simin Yang, Shangping Xing, Shanshan Wei, Jie Yang, Hongwei Guo, Zhuo Luo

Phytomedicine · 2026-09 · 159 · 158533

DOI: 10.1016/j.phymed.2026.158533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026-09. Verfasst von Yuting Yi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, Guangxi Medical University, Nanning, 530021, China. Hauptthemen laut MEDLINE: Polysaccharides, Gastrointestinal Microbiome, Orthomyxoviridae Infections, Abrus. Die Arbeit nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangxi Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND The gut microbiota is critical for host defense against influenza. Polysaccharides are known for their microbiota-modulating and immunomodulatory activities; however, the anti-influenza efficacy of homogeneous Abrus cantoniensis polysaccharides (ACP) remains unexplored. PURPOSE The present study seeks to clarify the protective role of ACP in influenza and explore its underlying molecular mechanisms. METHODS Initially, crude polysaccharides were extracted via ethanol precipitation and subsequently purified by gel chromatography. Systematic structural characterization of ACP was then performed using carbohydrate chemistry techniques, including scanning electron microscopy (SEM), Fourier-transform infrared spectroscopy (FTIR), ultraviolet (UV) spectroscopy, and nuclear magnetic resonance (NMR). The therapeutic efficacy of ACP was assessed by monitoring various indicators such as body weight, survival rate, viral load, and pulmonary pathological changes in mouse models. Furthermore, to elucidate the biological mechanism underlying ACP's anti-influenza activity via regulation of pulmonary interferon-beta (IFN-β) immune networks by intestinal acetate-producing microbiota, multi-omics analyses integrating metagenomics, metabolomics, gene knockout, immunofluorescence, and Western blot were conducted. Finally, the potential anti-influenza effects of ACP via the gut-lung axis were evaluated based on in vivo and in vitro detection of protein expression of IFN-β, free fatty acid receptor 2 (FFAR2), and mitochondrial antiviral signaling protein (MAVS), as well as antiviral interferon-stimulated genes (ISGs). RESULTS In this study, we purified a novel polysaccharide, ACP-A1, with a backbone of→4)-α-D-Glcp-(1→,→4)-β-D-Galp-(1→, and →4,6)-α-D-Glcp-(1→ linkages and α-D-Glcp-(1→ branches at O-6. In H1N1-infected mice, oral ACP-A1 alleviated weight loss, increased survival, and reduced lung inflammation and viral load. Metagenomic and targeted metabolomic analyses showed that ACP-A1 enriched Limosilactobacillus reuteri and elevated acetate levels. Fecal microbiota transplantation, FFAR2 inhibition, and MAVS knockout experiments demonstrated that ACP-A1 enhances the FFAR2/MAVS/IFN-β antiviral pathway via microbial-derived acetate. CONCLUSION Collectively, our findings elucidate that ACP mitigates influenza virus-induced lung dysfunction by promoting the proliferation of acetate-producing gut microbiota, particularly Limosilactobacillus reuteri, and activating the FFAR2/MAVS/IFN-β antiviral axis in pulmonary immune cells. These findings establish ACP-A1 as a natural polysaccharide regulating IFN-β homeostasis, highlighting its potential for influenza prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolysaccharidesGastrointestinal MicrobiomeOrthomyxoviridae InfectionsAbrusAntiviral AgentsAnimalsMiceSignal TransductionInterferon-betaFemaleMice, Inbred BALB CInfluenza A Virus, H1N1 SubtypeDogsMale

Stichwörter der Autor:innen

Abrus cantoniensis HanceAcetateAnti-influenzaGut microbiotaIFN-βPolysaccharide

Substanzen

PolysaccharidesAntiviral AgentsInterferon-beta

Autor:innen und Institutionen

  • Department of Pharmacology, School of Pharmacy, Guangxi Medical University, Nanning, 530021, China.
  • Department of Pharmacology, School of Pharmacy, Guangxi Medical University, Nanning, 530021, China; Department of Traditional Chinese Medicine, The First Clinical Medical School, Guangxi Medical University, Nanning, 530…
  • Department of Pharmacology, School of Pharmacy, Guangxi Medical University, Nanning, 530021, China; Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation, Pharmaceutical College, Guangxi Medical Universi…

Förderung

  • National Natural Science Foundation of China
  • Guangxi Natural Science Foundation

Zitieren

APA

Yi, Y., Li, D., Li, Y., Wang, H., Yang, D., Yang, S., Xing, S., Wei, S., Yang, J., Guo, H., & Luo, Z. (2026). Abrus cantoniensis α-glucan-like polysaccharide alleviates influenza via gut microbial acetate to activate free fatty acid receptor 2/ mitochondrial antiviral signaling protein/interferon-beta pathway. Phytomedicine, 159, 158533. https://doi.org/10.1016/j.phymed.2026.158533

Vancouver

Yi Y, Li D, Li Y, Wang H, Yang D, Yang S, et al. Abrus cantoniensis α-glucan-like polysaccharide alleviates influenza via gut microbial acetate to activate free fatty acid receptor 2/ mitochondrial antiviral signaling protein/interferon-beta pathway. Phytomedicine. 2026;159:158533. doi:10.1016/j.phymed.2026.158533

BibTeX
@article{Yi2026,
  author = {Yi, Yuting and Li, Dongdong and Li, Yuan and Wang, Haotong and Yang, Daxin and Yang, Simin and Xing, Shangping and Wei, Shanshan and Yang, Jie and Guo, Hongwei and Luo, Zhuo},
  title = {Abrus cantoniensis α-glucan-like polysaccharide alleviates influenza via gut microbial acetate to activate free fatty acid receptor 2/ mitochondrial antiviral signaling protein/interferon-beta pathway},
  journal = {Phytomedicine},
  year = {2026},
  volume = {159},
  pages = {158533},
  doi = {10.1016/j.phymed.2026.158533}
}
Kostenlos starten →